The FDA has issued a warning that certain anti-seizure drugs have been linked to an elevated risk of birth defects and should be avoided by pregnant women. The agency sent a letter to neurological and obstetric health workers warning that when taken by pregnant women, valproate sodium (marketed as Depacon), valproic acid (marketed as Depakene … Continue reading Anti-seizure drug linked to birth defects
Dr. Eddy Bettermann MD 